Abstract
Objectives
To develop an in vitro assay for quantitative analysis of the degradation to which a bone substitute is exposed by osteoclasts. The aim of establishing this method was to improve the predictability of carrying out tooth movements via bone substitutes and to provide a basis for verification in exemplary clinical cases.
Methods
After populating a bone substitute (NanoBone®; ArtOss, Germany) with osteoclastic cells, inductively-coupled mass spectrometry was used to evaluate changing calcium levels in the culture medium as a marker of resorption activity.
Results
It was observed that calcium levels increased substantially in the culture medium with the cells populating the bone substitute.
Conclusions
This in vitro assay is a valid method that can assist clinicians in selecting the appropriate materials for certain patients. While tooth movements occurring through this material were successful, uncertainty about the approach will remain as long-term results are not available.
Zusammenfassung
Zielsetzung
Das Ziel der Untersuchung war die Entwicklung eines In-vitro-Ansatzes zur Quantifizierung der Degradation eines Knochenersatzmaterials durch Osteoklasten. Auf Basis dieser Untersuchungen sollte die Zahnbewegung durch Knochenersatzmaterialien vorhersagbarer werden und in klinischen Beispielen überprüft werden.
Methode
Für die In-vitro-Untersuchung wurde ein Knochenersatzmaterial (NanoBone®, ArtOss, Deutschland) mit osteoklastären Zellen besiedelt und die Veränderungen der Kalziumkonzentration im Kulturmedium als Marker der Resorptionsaktiität mittels induktiver Massenspektrometrie gemessen.
Ergebnisse
In der in-vitro-Untersuchung zeigte sich über den Untersuchungszeitraum nach Besiedelung des Knochenersatzmaterials mit den Zellen eine deutliche Zunahme des Kalziumgehaltes im Kulturmedium.
Schlussfolgerung
Die hier beschriebene In-vitro-Methode ist ein valider Ansatz, die dem Behandler helfen kann die richtige Materialauswahl für seinen spezifischen Patienten zu treffen. Die Zahnbewegungen durch das hier beschrieben Material war erfolgreich, jedoch bleiben immer noch einige Unsicherheiten, da Langzeitergebnisse fehlen.
References
Alcaide M, Serrano MC, Pagani R et al (2009) L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-betaTCP/agarose biomaterial. J Biomed Mater Res A 2:539–549
Au AY, Au RY, Al-Talib TK et al (2008) Consil bioactive glass particles enhance osteoblast proliferation and maintain extracellular matrix production in vitro. J Biomed Mater Res A 3:678–684
Barka T, Anderson PJ (1962) Histochemical methods for acid phosphatase using hexazonium pararosaniline as coupler. J Histochem Cytochem 741–753
Blair HC (1998) How the osteoclast degrades bone. Bioessays 10:837–846
Bloemers FW, Blokhuis TJ, Patka P et al (2003) Autologous bone versus calcium-phosphate ceramics in treatment of experimental bone defects. J Biomed Mater Res B Appl Biomater 2:526–531
Cardaropoli D, Re S, Manuzzi W et al (2006) Bio-Oss collagen and orthodontic movement for the treatment of infrabony defects in the esthetic zone. Int J Periodontics Restorative Dent 26:553–559
Collin-Osdoby P, Yu X, Zheng H et al (2003) RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Med 80:153–166
Constantz BR, Barr BM, Ison IC et al (1998) Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res 4:451–461
Eriksen EF (2010) Cellular mechanisms of bone remodelling. Rev Endocr Metab Disord 11:219–227
Feinberg SE, Weisbrode SE, Heintschel G (1989) Radiographic and histological analysis of tooth eruption through calcium phosphate ceramics in the cat. Arch Oral Biol 34:975–984
Gomi K, Lowenberg B, Shapiro G et al (1993) Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. Biomaterials 2:91–96
Götz W, Lenz S, Reichert C et al (2010) A preliminary study in osteoinduction by a nano-crystalline hydroxyapatite in the mini pig. Folia Histochem Cytobiol 48:589–596
Götz W, Gerber T, Lossdörfer S et al (2008) Immunohistochemical characterization of nanocrystalline hydroxyapatite silica gel (NanoBone®) osteogenesis: a study on biopsies from human jaws. Clin Oral Implants Res 19:1016–1026
Holtgrave EA (1989) Inhibition of tooth eruption through calcium-phosphate ceramic granules in the rat. J Oral Maxillofac Surg 47:1043–1047
Habibovic P, de Groot K (2007) Osteoinductive biomaterials–properties and relevance in bone repair. J Tissue Eng Regen Med 1:25–32
Jones DH, Kong YY, Penninger JM (2002) Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis ii32–39
Kadoya Y, Al-Saffar N, Kobayashi A et al (1994) The expression of osteoclast markers on foreign body giant cells. Bone Miner 2:85–96
Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 6759:304–309
Kübler A, Neugebauer J, Oh JH et al (2004) Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. Implant Dent 2:171–179
Lossdörfer S, Götz W, Jäger A (2011) PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. Clin Oral Investig 15:941–952
Merten HA, Wiltfang J, Honig JF et al (2000) Intra-individual comparison of alpha- and beta-TCP ceramics in an animal experiment. Mund Kiefer Gesichtschir 4:509–515
Monchau F, Lefèvre A, Descamps M et al (2002) In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. Biomol Eng 2:143–152
Narducci P, Nicolin V (2009) Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study. Ann Anat 4:349–355
Perrotti V, Nicholls BM, Horton MA et al (2009) Human osteoclast formation and activity on a xenogenous bone mineral. J Biomed Mater Res A 1:238–246
Perrotti V, Nicholls BM, Piattelli A (2009) Human osteoclast formation and activity on an equine spongy bone substitute. Clin Oral Implants Res 1:17–23
Redey SA, Razzouk S, Rey C et al (1999) Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and natural calcium carbonate: relationship to surface energies. J Biomed Mater Res 2:140–147
Reichert C, Al-Nawas B, Smeets R et al (2009) In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives. Head Face Med 12:23–28
Reichert C, Götz W, Smeets R et al (2010) The impact of nonautogenous bone graft on orthodontic treatment. Quintessence Int 41:665–672
Reichert C, Wenghoefer M, Götz W et al (2011) Pilot study on orthodontic space closure after guided bone regeneration. J Orofac Orthop 72:45–50
Romas E, Bakharevski O, Hards DK et al (2000) Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 4:821–826
Rousselle AV, Heymann D (2002) Osteoclastic acidification pathways during bone resorption. Bone 4:533–540
Salo J, Lehenkari P, Mulari M et al (1997) Removal of osteoclast bone resorption products by transcytosis. Science 5310:270–273
Schilling AF, Linhart W, Filke S et al (2004) Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 18:3963–3972
Schneider B, Diedrich P (1989) Interaktion von kieferorthopädischer Zahnbewegung und Hydroxylapatit-Keramik. Dtsch Zahnärztl Zeitschr 44:282–285
Selby M, Hieftje GM (1987) Inductively coupled plasma-mass spectrometry: a status report. Am Lab 16, 18, 20–24, 26, 28
Shishatskaya EI, Volova TG, Puzyr AP et al (2004) Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci Mater Med 6:719–728
Silva I, Branco JC (2011) RANK/RANKL/OPG: literature review. Acta Reumatol Port 36:209–218
Taylor JC, Cuff SE, Leger JP et al (2002) In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study. Int J Oral Maxillofac Implants 17:321–330
Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 5484:1504–1508
Wada T, Hara K, Ozawa H (1989) Ultrastructural and histochemical study of beta-tricalcium phosphate resorbing cells in periodontium of dogs. J Periodontal Res 6:391–401
Weijs WL, Siebers TJ, Kuijpers-Jagtman AM et al (2010) Early secondary closure of alveolar clefts with mandibular symphyseal bone grafts and beta-tri calcium phosphate (beta-TCP). Int J Oral Maxillofac Surg 39:424–429
Wenisch S, Stahl JP, Horas U et al (2003) In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: fine structural microscopy. J Biomed Mater Res A 3:713–718
Wilcko WM, Wilcko MT, Bouquot JE et al (2001) Rapid orthodontics with alveolar reshaping: two case reports of decrowding. Int J Periodontics Restorative Dent 21:9–19
Yamaguchi M (2009) RANK/RANKL/OPG during orthodontic tooth movement. Orthod Craniofac Res 12:113–119
Zhang Z, Egaña JT, Reckhenrich AK et al (2012) Cell-based resorption assays for bone graft substitutes. Acta Biomater 8:13–19
Conflict of interest
On behalf of all authors, the corresponding author states the following: CR and WG are consultants for ArtOss.
Interessenkonflikt
Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehung/en hin: CR und WG sind als Referenten der Fa. ArtOss tätig.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reichert, C., Götz, W., Reimann, S. et al. Resorption behavior of a nanostructured bone substitute: in vitro investigation and clinical application. J Orofac Orthop 74, 165–175 (2013). https://doi.org/10.1007/s00056-012-0136-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00056-012-0136-6